Foresite Capital Management Iv, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Foresite Capital Management Iv, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$29.01 - $74.23 $4.54 Million - $11.6 Million	-156,355 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $4.3 Million - $8.96 Million	156,355 New	156,355 $5.32 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $17.4 Million - $24.5 Million	-425,794 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $145,632 - $192,735	-3,896 Reduced 0.91%	425,794 $17.8 Million
Q2 2019 Aug 13, 2019	SELL	$39.79 - $67.01 $3.54 Million - $5.96 Million	-88,870 Reduced 17.14%	429,690 $18.8 Million
Q1 2019 May 14, 2019	SELL	$34.52 - $53.29 $11.6 Million - $18 Million	-337,340 Reduced 39.41%	518,560 $26.7 Million
Q4 2018 Feb 13, 2019	BUY	$29.75 - $42.9 $139,825 - $201,630	4,700 Added 0.55%	855,900 $31.7 Million
Q1 2018 May 15, 2018	BUY	$22.49 - $34.56 $14.3 Million - $22 Million	637,765 Added 298.81%	851,200 $21.9 Million
Q4 2017 Feb 13, 2018	BUY	$20.44 - $35.56 $4.36 Million - $7.59 Million	213,435	213,435 $5.76 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.